LeonaBio (LONA) Assets Average (2020 - 2026)

LeonaBio (LONA) has 7 years of Assets Average data on file, last reported at $81.9 million in Q1 2026.

• On a quarterly basis, Assets Average rose 60.07% year-over-year to $81.9 million in Q1 2026; TTM through Mar 2026 was $81.9 million, a 60.07% increase from a year earlier, with the FY2025 full-year figure at $75.5 million, down 31.09% from the prior year.
• Assets Average for Q1 2026 stood at $81.9 million, up from $61.1 million in the prior quarter.
• Over the last five years, Assets Average for LONA reached as high as $322.5 million in Q1 2022 and fell as low as $32.8 million in Q3 2025.
• Historically, Assets Average has averaged $159.8 million across 5 years, with a median of $146.9 million in 2024.
• Across the five-year window, Assets Average plunged 67.69% in 2025 and surged 60.07% in 2026, its largest moves.
• Year by year, Assets Average stood at $266.2 million in 2022, then slumped by 35.2% to $172.5 million in 2023, then plunged by 57.96% to $72.5 million in 2024, then decreased by 15.75% to $61.1 million in 2025, then jumped by 34.01% to $81.9 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $81.9 million in Q1 2026, $61.1 million in Q4 2025, and $32.8 million in Q3 2025.